Mazor Robotics has declared that it has been granted the U.S. Food and Drug Administration (FDA) clearance for the promotion of Emerald, robot-guided surgical implants used in spine surgeries.
Mazor Robotics’ SpineAssist is a surgical robot, enabling surgeons to safely and precisely perform spine fixation procedures. The robotic system includes a robot and a workstation featuring the sophisticated surgical scheduling software. During the surgery, the robot is mounted on the patient’s spine. In multiple spine surgeries, the vertebrae are gripped by Emerald implants.
Ori Hadomi, CEO of Mazor Robotics, has stated that they are confident that their SpineAssist surgical system will fortify their position in the spinal procedures segment. He added that Emerald implants are exclusively developed to function along with the Spine Assist for effective assistance during spine surgery, helping both surgeons and patients.
The Emerald implant effectively endured all the regulatory and bio-mechanical conformity requirements of the FDA. In addition, top surgeons in Europe and the US also supported the development of this surgical implant. Marketing of Emerald is likely to begin in the second half of this year.
Source: http://www.mazorrobotics.com